PLoS Pathogens · 2022 · 27 citations · 66 references
MedicineGeneticsInfectious DiseasesGenome EditingMolecular OncologyNeoplasiaBiliary Tract CancerCancer BiotechnologyCancer Molecular PathologyHepatobiliary CancerLiver CancerLiver DiseaseCrispr-cas9 Genome EditingCrispr-cas9 KnockoutGene KnockoutHepatic Fluke InfectionLiver Fluke InfectionsNitrosamine ExposureRna-guided Gene KnockoutTargeted Gene Knockout
Infection with the food-borne liver fluke Opisthorchis viverrini is the principal risk factor for cholangiocarcinoma (CCA) in the Mekong Basin countries of Thailand, Lao PDR, Vietnam, Myanmar and Cambodia. Using a novel model of CCA, involving infection with gene-edited liver flukes in the hamster during concurrent exposure to dietary nitrosamine, we explored the role of the fluke granulin-like growth factor Ov-GRN-1 in malignancy. We derived RNA-guided gene knockout flukes (ΔOv-grn-1) using CRISPR/Cas9/gRNA materials delivered by electroporation. Genome sequencing confirmed programmed Cas9-catalyzed mutations of the targeted genes, which was accompanied by rapid depletion of transcripts and the proteins they encode. Gene-edited parasites colonized the biliary tract of hamsters and developed into adult flukes. However, less hepatobiliary tract disease manifested during chronic infection with ΔOv-grn-1 worms in comparison to hamsters infected with control gene-edited and mock-edited parasites. Specifically, immuno- and colorimetric-histochemical analysis of livers revealed markedly less periductal fibrosis surrounding the flukes and less fibrosis globally within the hepatobiliary tract during infection with ΔOv-grn-1 genotype worms, minimal biliary epithelial cell proliferation, and significantly fewer mutations of TP53 in biliary epithelial cells. Moreover, fewer hamsters developed high-grade CCA compared to controls. The clinically relevant, pathophysiological phenotype of the hepatobiliary tract confirmed a role for this secreted growth factor in malignancy and morbidity during opisthorchiasis.
66
Genome engineering using the CRISPR-Cas9 system
F. Ann Ran, Patrick D. Hsu, Jason Wright et al. · Nature Protocols · 2013 · 11.7K citations · Full text
CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia
Haydar Frangoul, David Altshuler, Maria Domenica Cappellini et al. · New England Journal of Medicine · 2020 · 1.9K citations · Full text
Life Sciences, Genetics, Hematology +17
CHOPCHOP: a CRISPR/Cas9 and TALEN web tool for genome editing
Tessa G. Montague, José Manuel Bautista Santa Cruz, James A. Gagnon et al. · Nucleic Acids Research · 2014 · 1.3K citations · Full text
CHOPCHOP v2: a web tool for the next generation of CRISPR genome engineering
Kornel Labun, Tessa G. Montague, James A. Gagnon et al. · Nucleic Acids Research · 2016 · 1.1K citations · Full text